90047593 - INNATUS

Information

• Trademark
• 90047593

• Source

• Serial Number

  90047593

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 10, 2020
  4 years ago

• Transaction Date

  May 07, 2021
  3 years ago

• Status Date

  May 07, 2021
  3 years ago

• Location Date

  May 07, 2021
  3 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  LEVINE, HOWARD B

• Attorney Docket Number

  37070-00070

  Attorney Name

  Mark Jansen

  Law Office Assigned Location Code

  M60

• Owners

  • Incysus Therapeutics, Inc.

Case File Statements

• GS0051: Pharmaceutical preparations, namely, oncological preparations; Reagents, diagnostics and therapeutic preparations for medical use in oncology; Targeted medical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of cancer and tumors; Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; Pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; Medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; Pharmaceutical and biological preparations comprised of modified T cells used for multiple modes of treatment against tumor resistance and immunosuppression
• GS0421: Research, development, and evaluation of new products; Pharmaceutical, medicine, and vaccine research and development services; Technical research in the field of pharmaceutical studies; Laboratory analysis and research into new drugs and pharmaceutical products; Development of measuring and testing methods in the field of medicine; Design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; Research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; Providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; Scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology

Case File Event Statements

• 5/7/2021 - 3 years ago

  8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 5/7/2021 - 3 years ago

  7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 10/20/2020 - 3 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/20/2020 - 3 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/20/2020 - 3 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/20/2020 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/7/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/14/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP